BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2021
View Archived Issues
COVID-19 vaccine EXG-5003 enters first-in-human study
Read More
AbbVie initiates phase Ib/II trial of ABBV-927 in untreated metastatic pancreatic adenocarcinoma
Read More
First patient dosed in pivotal phase II FIREFLY-1 study of DAY-101 in pediatric low-grade glioma
Read More
FDA clears IND for icapamespib for the treatment of recurrent malignant glioma
Read More
Positive data presented from MAD phase I study of CTI-1601 in Friedreich's ataxia
Read More
Foghorn Therapeutics announces FDA clearance of its IND applications
Read More
S-540956 shows potent in vivo activity as adjuvant for cancer peptide vaccine
Read More
BIRKI, a novel ROCK inhibitor as potential new therapy for diabetic retinopathy
Read More
Novartis patents new antimalarials
Read More
Alairion presents histamine H1 receptor inverse agonists and 5-HT2A receptor antagonists
Read More
Sentinel Oncology identifies Wee1 and PLK1 inhibitors
Read More
Ambys Medicines presents new tropolone derivatives
Read More
New FGFR inhibitors presented by Incyte
Read More
New phase I/II study evaluates CAM-H2 in advanced HER2-positive breast, gastric and GEJ cancers
Read More
Reistone begins phase III trial of oral SHR-0302 in moderate to severe atopic dermatitis
Read More
In immunity, IL-33 signals stop as well as go
Read More
Dose expansion begins in phase I/II study of darovasertib and crizotinib in MUM
Read More
GTA-002 shows antitumoral activity against melanoma cells
Read More
Minerva reports phase III OLE data on roluperidone for negative symptoms of schizophrenia
Read More
Phase IIb trial investigates ABTL-0812 with FOLFIRINOX in pancreatic cancer
Read More
Topline data from U.S. phase II IXPLORE study of vilobelimab in AAV
Read More
Takeda reports interim Japanese phase I/II data on Moderna's mRNA COVID-19 vaccine candidate
Read More
NVX-CoV2373 vaccine shows efficacy against the B.1.351 variant of COVID-19
Read More
